Results 331 to 340 of about 76,334 (347)

Diagnostic Value of Serum Levels of GFAP, pNF-H, and NSE Compared With Clinical Findings in Severity Assessment of Human Traumatic Spinal Cord Injury

Spine, 2015
Reza Ahadi, F. Khodagholi, A. Daneshi, A. Vafaei, A. Mafi, M. Jorjani   +5 more
semanticscholar   +1 more source

Plasma S100β and NSE levels and progression in multiple sclerosis

Journal of the Neurological Sciences, 2007
Marcus W Koch, Jop Mostert, Jacques De Keyser   +2 more
exaly  

Association of ICP, CPP, CT findings and S-100B and NSE in severe traumatic head injury. Prognostic value of the biomarkers

Brain Injury, 2015
Zandra Olivecrona, L. Bobinski, L. Koskinen   +2 more
semanticscholar   +1 more source

Prognostic Value of Tumor Markers, NSE, CA125 and SCC, in Operable NSCLC Patients

International Journal of Molecular Sciences, 2013
Guojun Chen
exaly  

Immunohistochemical Investigation of S100 and NSE in Cases of Traumatic Brain Injury and Its Application for Survival Time Determination

Journal of Neurotrauma, 2015
Michaela Krohn, J. Dressler, M. Bauer, K. Schober, H. Franke, B. Ondruschka   +5 more
semanticscholar   +1 more source

S-100B and NSE: markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome

Journal of Clinical Neuroscience, 2006
Matthias Oertel, David L Mcarthur
exaly  

Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder

World Journal of Biological Psychiatry, 2015
F. Schmidt, R. Mergl, B. Stach, I. Jahn, P. Schönknecht   +4 more
semanticscholar   +1 more source

Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer

Respiratory Medicine, 2004
Fabrice Barlesi, Christophe Doddoli, Julien Mancini   +2 more
exaly  

Serum NSE level and disability progression in multiple sclerosis.

Journal of Neurological Sciences, 2015
M. Koch, S. George, W. Wall, V. Wee Yong, L. Metz   +4 more
semanticscholar   +1 more source

Serum NSE, CEA, CT, CA 15-3 Levels in Human Lung Cancer

International Journal of Biological Markers, 1990
Gianni Cappelli
exaly